{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:12:46Z","timestamp":1780791166125,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010327","name":"Cincinnati Children\u2019s Research Foundation","doi-asserted-by":"publisher","award":["Procter K-to-R Transition Award"],"award-info":[{"award-number":["Procter K-to-R Transition Award"]}],"id":[{"id":"10.13039\/100010327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R21HD092896"],"award-info":[{"award-number":["R21HD092896"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM126943"],"award-info":[{"award-number":["R35 GM126943"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Sepsis is associated with significant mortality. Yet, there are no efficacious therapies beyond antibiotics.\n                      <jats:italic>PCSK9<\/jats:italic>\n                      loss-of-function (LOF) and inhibition, through enhanced low-density lipoprotein receptor (LDLR)\u00a0mediated endotoxin clearance, holds promise as a potential therapeutic approach among adults. In contrast, we have previously demonstrated higher mortality in the juvenile host. Given the potential pleiotropic effects of PCSK9 on the endothelium, beyond  canonical\u00a0effects on serum lipoproteins, both of which may influence sepsis outcomes, we sought to test the influence of\n                      <jats:italic>PCSK9<\/jats:italic>\n                      LOF genotype on endothelial dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Secondary analyses of a prospective observational cohort of pediatric septic shock. Genetic variants of\n                      <jats:italic>PCSK9<\/jats:italic>\n                      and\n                      <jats:italic>LDLR<\/jats:italic>\n                      genes, serum PCSK9, and lipoprotein concentrations were determined previously. Endothelial dysfunction markers were measured in day 1 serum. We conducted multivariable linear regression to test the influence of\n                      <jats:italic>PCSK9<\/jats:italic>\n                      LOF genotype on endothelial markers, adjusted for age, complicated course, and low- and high-density lipoproteins (LDL and HDL). Causal mediation analyses to test impact of select endothelial markers on the association between\n                      <jats:italic>PCSK9<\/jats:italic>\n                      LOF genotype and mortality. Juvenile\n                      <jats:italic>Pcsk9<\/jats:italic>\n                      null and wildtype mice were subject to cecal slurry sepsis and endothelial markers were quantified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 474 patients were included.\n                      <jats:italic>PCSK9<\/jats:italic>\n                      LOF was associated with several markers of endothelial dysfunction, with strengthening of associations after exclusion of those homozygous for the rs688\n                      <jats:italic>LDLR<\/jats:italic>\n                      variant that renders it insensitive to PCSK9. Serum PCSK9 was not correlated with endothelial dysfunction.\n                      <jats:italic>PCSK9<\/jats:italic>\n                      LOF influenced concentrations of Angiopoietin-1 (Angpt-1) upon adjusting for potential confounders including lipoprotein concentrations, with false discovery adjusted p value of 0.042 and 0.013 for models that included LDL and HDL, respectively. Causal mediation analysis demonstrated that the effect of\n                      <jats:italic>PCSK9<\/jats:italic>\n                      LOF on mortality was mediated by Angpt-1 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0008). Murine data corroborated these results with lower Angpt-1 and higher soluble thrombomodulin among knockout mice with sepsis relative to the wildtype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We present genetic and biomarker association data that suggest a potential direct role of the PCSK9-LDLR pathway on Angpt-1 in the developing host with septic shock and warrant external validation. Further, mechanistic studies on the role of PCSK9-LDLR pathway on vascular homeostasis may lead to the development of pediatric-specific sepsis therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04535-1","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T04:10:58Z","timestamp":1687752658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1"],"prefix":"10.1186","volume":"27","author":[{"given":"Mihir R.","family":"Atreya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie Z.","family":"Cvijanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Bigham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag N.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Lutfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn R.","family":"Grunwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torrey","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Quasney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bereketeab","family":"Haileselassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett","family":"Ripberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adesuwa","family":"Ekunwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Standage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"4535_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395:200\u201311.","journal-title":"The Lancet"},{"key":"4535_CR2","unstructured":"Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. World Health Organization. 2020. p.56 https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/334216\/9789240010789-eng.pdf?sequence=1&isAllowed=y."},{"key":"4535_CR3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamapediatrics.2019.2570","volume":"173","author":"EF Carlton","year":"2019","unstructured":"Carlton EF, Barbaro RP, Iwashyna T. \u201cJack\u201d & Prescott, H. C. Cost of pediatric severe sepsis hospitalizations. JAMA Pediatr. 2019;173:986\u20137.","journal-title":"JAMA Pediatr"},{"key":"4535_CR4","doi-asserted-by":"publisher","first-page":"258ra43","DOI":"10.1126\/scitranslmed.3008782","volume":"6","author":"KR Walley","year":"2014","unstructured":"Walley KR, et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Transl Med. 2014;6:258ra43.","journal-title":"Sci Transl Med"},{"key":"4535_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000442976","volume":"8","author":"JH Boyd","year":"2016","unstructured":"Boyd JH, et al. Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis. J Innate Immun. 2016;8:211\u201320.","journal-title":"J Innate Immun"},{"key":"4535_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/SHK.0000000000000682","volume":"46","author":"DJ Dwivedi","year":"2016","unstructured":"Dwivedi DJ, et al. Differential expression of PCSK9 modulates infection, inflammation, and coagulation in a murine model of sepsis. Shock. 2016;46:672\u201380.","journal-title":"Shock"},{"key":"4535_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155030","volume":"11","author":"E Topchiy","year":"2016","unstructured":"Topchiy E, et al. Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor. PLoS ONE. 2016;11: e0155030.","journal-title":"PLoS ONE"},{"key":"4535_CR8","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1038\/s41598-018-28777-0","volume":"8","author":"PM Grin","year":"2018","unstructured":"Grin PM, et al. Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor. Sci Rep. 2018;8:10496.","journal-title":"Sci Rep"},{"key":"4535_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.11130","volume":"2","author":"Q Feng","year":"2019","unstructured":"Feng Q, et al. A genetic approach to the association between PCSK9 and sepsis. JAMA Netw Open. 2019;2: e1911130.","journal-title":"JAMA Netw Open"},{"key":"4535_CR10","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/CCM.0000000000004487","volume":"48","author":"MR Atreya","year":"2020","unstructured":"Atreya MR, et al. Proprotein convertase subtilisin\/kexin type 9 loss-of-function is detrimental to the juvenile host with septic shock. Crit Care Med. 2020;48:1513\u201320.","journal-title":"Crit Care Med"},{"key":"4535_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/joim.12946","volume":"286","author":"J Rannikko","year":"2019","unstructured":"Rannikko J, et al. Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality. J Intern Med. 2019;286:553\u201361.","journal-title":"J Intern Med"},{"key":"4535_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/joim.13150","volume":"289","author":"A Vecchi\u00e9","year":"2021","unstructured":"Vecchi\u00e9 A, et al. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study. J Intern Med. 2021;289:179\u201392.","journal-title":"J Intern Med"},{"key":"4535_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","volume":"202","author":"J Joffre","year":"2020","unstructured":"Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202:361\u201370.","journal-title":"Am J Respir Crit Care Med"},{"key":"4535_CR14","doi-asserted-by":"publisher","first-page":"ehab724.3436","DOI":"10.1093\/eurheartj\/ehab724.3436","volume":"42","author":"T Leucker","year":"2021","unstructured":"Leucker T, Amat-Codina N, Chelko S, Gerstenblith G. Proprotein convertase subtilisin\/kexin type 9 links inflammation to vascular endothelial cell dysfunction. Eur Heart J. 2021;42:ehab724.3436.","journal-title":"Eur Heart J"},{"key":"4535_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2022.09.008","author":"AKK Leung","year":"2022","unstructured":"Leung AKK, et al. Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9. Atherosclerosis. 2022. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.09.008.","journal-title":"Atherosclerosis"},{"issue":"3","key":"4535_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/metabo12030226","volume":"12","author":"M Puccini","year":"2022","unstructured":"Puccini M, Landmesser U, Rauch U. Pleiotropic effects of PCSK9: focus on thrombosis and haemostasis. Metabolites. 2022;12(3):226. https:\/\/doi.org\/10.3390\/metabo12030226.","journal-title":"Metabolites"},{"key":"4535_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13054-020-02860-3","volume":"24","author":"S Tanaka","year":"2020","unstructured":"Tanaka S, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24:134.","journal-title":"Crit Care"},{"key":"4535_CR18","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/jcm10081693","volume":"10","author":"G Barker","year":"2021","unstructured":"Barker G, et al. Lipid and lipoprotein dysregulation in sepsis: clinical and mechanistic insights into chronic critical illness. J Clin Med. 2021;10:1693.","journal-title":"J Clin Med"},{"key":"4535_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.nut.2017.09.015","volume":"47","author":"ACG Bermudes","year":"2018","unstructured":"Bermudes ACG, et al. Changes in lipid metabolism in pediatric patients with severe sepsis and septic shock. Nutrition. 2018;47:104\u20139.","journal-title":"Nutrition"},{"key":"4535_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2\u20138.","journal-title":"Pediatr Crit Care Med"},{"key":"4535_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/liv.13978","volume":"39","author":"GS Steba","year":"2019","unstructured":"Steba GS, et al. SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibility. Liver Int. 2019;39:463\u20139.","journal-title":"Liver Int"},{"key":"4535_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13054-022-04070-5","volume":"26","author":"MR Atreya","year":"2022","unstructured":"Atreya MR, et al. Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study. Crit Care. 2022;26:210.","journal-title":"Crit Care"},{"key":"4535_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11306-009-0174-2","volume":"5","author":"AM Zivkovic","year":"2009","unstructured":"Zivkovic AM, et al. Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics. 2009;5:507\u201316.","journal-title":"Metabolomics"},{"key":"4535_CR24","unstructured":"National Research Council (US) Committee for the Update of the Guide for theCare and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. (National Academies Press (US), 2011)."},{"key":"4535_CR25","doi-asserted-by":"crossref","unstructured":"Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. mediation\u202f: R package for causal mediation analysis. J Stat Soft. 2014: 59.","DOI":"10.18637\/jss.v059.i05"},{"key":"4535_CR26","unstructured":"2212PCSK9 inhibition decreases endothelial nitric oxide synthase activation in response to inflammatory conditions in endothelial cells | European Heart Journal | Oxford Academic. https:\/\/academic.oup.com\/eurheartj\/article\/38\/suppl_1\/ehx502.2212\/4088359"},{"key":"4535_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fimmu.2018.00838","volume":"9","author":"A Leligdowicz","year":"2018","unstructured":"Leligdowicz A, Richard-Greenblatt M, Wright J, Crowley VM, Kain KC. Endothelial activation the Ang\/Tie axis in sepsis. Front Immunol. 2018;9:838.","journal-title":"Front Immunol"},{"key":"4535_CR28","doi-asserted-by":"publisher","first-page":"598649","DOI":"10.3389\/fphys.2020.598649","volume":"11","author":"K-D Schl\u00fcter","year":"2020","unstructured":"Schl\u00fcter K-D, Wolf A, Schreckenberg R. Coming back to physiology: extra hepatic functions of proprotein convertase Subtilisin\/Kexin Type 9. Front Physiol. 2020;11:598649.","journal-title":"Front Physiol"},{"key":"4535_CR29","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375:2144\u201353.","journal-title":"N Engl J Med"},{"key":"4535_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0009922811430344","volume":"51","author":"AC Skinner","year":"2012","unstructured":"Skinner AC, Steiner MJ, Chung AE, Perrin EM. Cholesterol curves to identify population norms by age and sex in healthy weight children. Clin Pediatr (Phila). 2012;51:233\u20137.","journal-title":"Clin Pediatr (Phila)"},{"key":"4535_CR31","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.3390\/ijerph111010663","volume":"11","author":"B Downer","year":"2014","unstructured":"Downer B, Estus S, Katsumata Y, Fardo DW. Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status. Int J Environ Res Public Health. 2014;11:10663\u201393.","journal-title":"Int J Environ Res Public Health"},{"key":"4535_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0304-4157(83)90001-1","volume":"737","author":"RW Mahley","year":"1983","unstructured":"Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta. 1983;737:197\u2013222.","journal-title":"Biochim Biophys Acta"},{"key":"4535_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1161\/01.ATV.19.4.832","volume":"19","author":"P Parini","year":"1999","unstructured":"Parini P, Angelin B, Rudling M. Cholesterol and lipoprotein metabolism in aging. Arterioscler Thromb Vasc Biol. 1999;19:832\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4535_CR34","doi-asserted-by":"publisher","unstructured":"Lagger, C. et al. scAgeCom: a murine atlas of age-related changes in intercellular communication inferred with the package scDiffCom. http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2021.08.13.456238 (2021) doi:https:\/\/doi.org\/10.1101\/2021.08.13.456238.","DOI":"10.1101\/2021.08.13.456238 10.1101\/2021.08.13.456238"},{"key":"4535_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11010-011-1028-6","volume":"359","author":"C-Y Wu","year":"2012","unstructured":"Wu C-Y, et al. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl\/Bax-caspase9-caspase3 pathway. Mol Cell Biochem. 2012;359:347\u201358.","journal-title":"Mol Cell Biochem"},{"key":"4535_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jacc.2022.10.030","volume":"81","author":"EP Navarese","year":"2023","unstructured":"Navarese EP, et al. PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection. J Am Coll Cardiol. 2023;81:224\u201334.","journal-title":"J Am Coll Cardiol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04535-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:19:34Z","timestamp":1687796374000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04535-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4535"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04535-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2521836\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Keith R. Walley and the University of British Columbia hold patents for the use of human anti-PCSK9 antibody as a sepsis therapeutic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from the parent or guardian of patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards of participating institutions and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"K.R.W and the University of British Columbia hold patents for the use of human anti-PCSK9 antibody as a sepsis therapeutic.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}